Berenberg Bank Analysts Give MorphoSys (ETR:MOR) a €65.00 Price Target

MorphoSys (ETR:MORGet Rating) has been given a €65.00 ($67.01) target price by stock analysts at Berenberg Bank in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. Berenberg Bank’s price target indicates a potential upside of 189.79% from the company’s previous close.

Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. set a €34.00 ($35.05) price target on shares of MorphoSys in a research report on Tuesday, July 26th. Deutsche Bank Aktiengesellschaft set a €30.00 ($30.93) price target on shares of MorphoSys in a research report on Wednesday, July 27th. Finally, The Goldman Sachs Group set a €24.00 ($24.74) price target on shares of MorphoSys in a research report on Friday, June 10th.

MorphoSys Trading Up 1.3 %

Shares of MOR stock opened at €22.43 ($23.12) on Thursday. The company’s 50-day moving average price is €20.55 and its 200-day moving average price is €22.58. The company has a current ratio of 2.98, a quick ratio of 2.71 and a debt-to-equity ratio of 231.51. The stock has a market cap of $765.96 million and a price-to-earnings ratio of -1.25. MorphoSys has a twelve month low of €16.45 ($16.96) and a twelve month high of €51.60 ($53.20).

MorphoSys Company Profile

(Get Rating)

MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for MorphoSys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MorphoSys and related companies with MarketBeat.com's FREE daily email newsletter.